Brandinium

Trademark search for:

SYMLIN SUPPORT PROGRAM

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2011-03-02 — Application filed
  • 2011-03-05 — Application filed
  • 2011-03-07 — Application filed
  • 2011-03-08 — Notice of design search code mailed
  • 2011-05-18 — Assigned to examiner
  • 2011-05-25 — Final disposition recorded
  • 2011-05-25 — Final disposition recorded
  • 2011-05-25 — Final disposition recorded
  • 2011-09-01 — Attorney/dom.rep.revoked and/or appointed
  • 2011-09-01 — Teas revoke/app/change addr of atty/dom rep received
  • 2011-09-09 — Office action issued
  • 2011-09-09 — Correspondence received in law office
  • 2011-09-10 — Teas/email correspondence entered
  • 2011-09-22 — Attorney/dom.rep.revoked and/or appointed
  • 2011-09-22 — Teas revoke/app/change addr of atty/dom rep received
  • 2011-10-04 — Approved for pub - principal register
  • 2011-11-01 — Assigned to lie
  • 2011-11-02 — Law office publication review completed
  • 2011-11-16 — Notification of notice of publication e-mailed
  • 2011-12-06 — Published for opposition
  • 2011-12-06 — Official gazette publication confirmation e-mailed
  • 2012-02-21 — Registered-principal register
  • 2012-10-31 — Automatic update of assignment of ownership
  • 2013-05-29 — Attorney/dom.rep.revoked and/or appointed
  • 2013-05-29 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-03-24 — Attorney/dom.rep.revoked and/or appointed
  • 2014-03-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-02-21 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2018-09-28 — Cancelled sec. 8 (6-yr)
  • 2018-09-28 — Final status recorded

Owner Information

AMYLIN PHARMACEUTICALS, LLC
SAN DIEGO , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA
Amylin Pharmaceuticals, Inc.
San Diego , CA

Correspondent

Marc Stanislawczyk AstraZeneca Pharmaceuticals LP
1800 Concord Pike
FOP3-022
Wilmington, DE 19850-5437

Filing Details

Filing Date:
2011-03-02
Status Date:
2018-09-28
Filing Year:
2011

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.